InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain
InhaleRX Ltd has received approval for a Phase 2 clinical trial to test its novel therapy IRX-211 for treatment of Breakthrough Cancer Pain
OOO
2.81%
$19.36
BETASHARES CRUDE OIL INDEX ETF-CURRENCY HEDGED (SYNTHETIC)
Currently unlisted.
Add to my watchlist
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
OOO | Ann: Interim Financial Report | 12/03/19 | 0 | 67 | |||
|
|||||||
OOO | Ann: Units on Issue Disclosure - February 2019 | 06/03/19 | 0 | 85 | |||
|
|||||||
OOO | Ann: Units on Issue Disclosure - January 2019 | 06/02/19 | 0 | 70 | |||
|
|||||||
OOO | Ann: Units on Issue Disclosure - December 2018 | 07/01/19 | 0 | 92 | |||
|
|||||||
OOO | Ann: Units on Issue Disclosure - November 2018 | 04/12/18 | 0 | 70 | |||
|
|||||||
OOO | Ann: Units on Issue Disclosure - October 2018 | 06/11/18 | 0 | 78 | |||
|
|||||||
OOO | Ann: Change to Opening Trading Time | 05/10/18 | 0 | 152 | |||
|
|||||||
OOO | Ann: Units on Issue Disclosure - September 2018 | 05/10/18 | 0 | 95 | |||
|
See All Discussions